In 2011, a year before the outbreak, the Colorado State Board of Pharmacy detected problems with the NECC when it was determined that the company was distributing compounded drugs in our state that had been manufactured ahead of time without first obtaining patient-specific prescriptions. This left Colorado patients at risk for being given a medication not appropriate for their specific medical needs and necessary health requirements.
Our state board issued a cease-and-desist order to the NECC, and notified the Massachusetts Board as well. But that was all it could do; ultimately, it was not enough to stop the NECC’s actions and prevent the tragic outbreak that swept across the nation a year later. Despite Colorado’s warnings, the state of Massachusetts did not act and, because it was hamstrung by existing regulations, the FDA could not act, either.
quoted from here
quoted from here
No comments:
Post a Comment